Costly, aggressive treatments often used on end-stage cancer patients

Mackenzie Bean - Print  | 

Many patients with late-stage cancers pursue aggressive treatment options instead of end-of-life care, according to a study published in JNCI Cancer Spectrum.

For the study, researchers examined clinical data on 100,848 metastatic lung, colorectal, breast and pancreatic cancer patients from the National Cancer Data Base. Patients all died within one month of being diagnosed between 2004 and 2014. 

They found treatments varied based on cancer type, age, insurance and type of healthcare facility. However, many patients still sought aggressive treatments despite the advanced stage of their cancers. About 28 percent of colorectal cancer patients underwent surgery, and 18.7 percent of lung cancer patients had radiation.

The researchers concluded more research is needed to better identify cancer patients who will not benefit from these types of aggressive and expensive treatments.

More articles on clinical leadership & infection control:
Report: Veteran's leg amputated after VA fails to log home care appointments
ICU healthcare workers have low hand hygiene compliance, study finds
Duodenoscope contamination rates higher than expected, says FDA

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.